Patent · US Active

Mouse-adapted SARS-CoV-2 viruses and methods of use thereof

US11225508B1 · kind B1 · utility

10Cited by

7References

22Claims

0Family size

Assignee

The University of North Carolina at Chapel Hill · US

Inventors

Ralph Baric · Haw River, US
Kenneth Harold Dinnon, III · Chapel Hill, US
Sarah Rebecca Leist · Carrboro, US

Key dates

Filing date	Feb 11, 2021
Grant date	Jan 18, 2022
Priority date	—
Expiry date	Feb 11, 2041

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2770/36143
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

This invention relates to SARS-CoV-2 viruses adapted with nanoluciferase reporter molecules and mouse-adapted SARS-CoV-2 viruses, compositions including the same and methods of use thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.